Unknown

Dataset Information

0

Lefamulin. Comment on: "Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms. Microorganisms, 2019, 7, 270".


ABSTRACT: On 18 August 2019, an article was published in Microorganisms presenting novel, approved anti-Gram-positive antibiotics. On 19 August 2019, the U.S. Food and Drug Administration announced the approval of lefamulin, a representative of a new class of antibiotics, the pleuromutilins, for the treatment of adult community-acquired bacterial pneumonia. We present a brief description of lefamulin.

SUBMITTER: Koulenti D 

PROVIDER: S-EPMC6843636 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lefamulin. Comment on: "Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms. <i>Microorganisms</i>, 2019, <i>7</i>, 270".

Koulenti Despoina D   Xu Elena E   Yin Sum Mok Isaac I   Song Andrew A   Karageorgopoulos Drosos E DE   Armaganidis Apostolos A   Lipman Jeffrey J   Tsiodras Sotirios S  

Microorganisms 20190924 10


On 18 August 2019, an article was published in <i>Microorganisms</i> presenting novel, approved anti-Gram-positive antibiotics. On 19 August 2019, the U.S. Food and Drug Administration announced the approval of lefamulin, a representative of a new class of antibiotics, the pleuromutilins, for the treatment of adult community-acquired bacterial pneumonia. We present a brief description of lefamulin. ...[more]

Similar Datasets

| S-EPMC6723731 | biostudies-literature
| S-EPMC7074912 | biostudies-literature
| S-EPMC5874163 | biostudies-literature
| S-EPMC9618150 | biostudies-literature
| S-EPMC7962006 | biostudies-literature
| S-EPMC4054986 | biostudies-literature
| S-EPMC9807916 | biostudies-literature
| S-EPMC1479125 | biostudies-literature
| S-EPMC11362173 | biostudies-literature
| S-EPMC7601562 | biostudies-literature